Akash G. Patel

Akash G. Patel

Auto-generated profile, based on publicly available information

Akash G. Patel

NYU Grossman School of Medicine, New York, NY USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
PNPramod N. Nehete
Pramod N. Nehete
BNBharti P. Nehete
Bharti P. Nehete
APAkash G. Patel
Akash G. Patel
SCSriram Chitta
Sriram Chitta
HSHenrieta Scholtzova
Henrieta Scholtzova
LWLawrence E. Williams
Lawrence E. Williams
Nonhuman primates are frequently transported to a new location or temporarily relocated within their colony. Both transportation and relocation expose animals to new environments, causing them to undergo a stress response (before adapting). In our NHP colony, the mentioned situations are not infrequent for many reasons, including maintenance. The objective of this study was to determine whether abrupt changes consisting of relocation, housing, separation, and grouping could influence hematological and immunological parameters and thereby functional activity. The current study used squirrel monkeys as a model to investigate the stress-inducing effects of relocation within a facility, while animals acclimated to new situations (physical, housing). A detailed blood analysis revealed significant changes in lymphocytes, triglycerides, total protein, creatinine, and ALT. Flow cytometric analysis of peripheral blood showed reduction in CD3+, CD4+, and CD8+ T cells and monocytes, while B cells and natural killer (NK) cells changed with relocation. Simultaneously, changes in functional activity of immune cells altered proliferative responses and as shown by ELISpot (IFN γ). Though the parameters studied are not affected as severely as those in animals transported by road or air, stress responses induced by intrafacility relocation are significant and worth consideration. Our findings indicate that squirrel monkeys mimic the features seen in humans exposed to social stressors and may serve an important model for understanding the mechanisms of stress-induced immune dysfunction in humans.

31 December 2021 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
APAkash G Patel
Akash G Patel
PNPramod N Nehete
Pramod N Nehete
BNBharti P Nehete
Bharti P Nehete
SKSohail G Karimi
Sohail G Karimi
TGThomas S Genovese
Thomas S Genovese
HSHenrieta Scholtzova
Henrieta Scholtzova

7 December 2020 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
APAkash G. Patel
Akash G. Patel
PNPramod N. Nehete
Pramod N. Nehete
BNBharti P. Nehete
Bharti P. Nehete
DGDaniel Ezra Guttman
Daniel Ezra Guttman
YKYena Kwak
Yena Kwak
HSHenrieta Scholtzova
Henrieta Scholtzova

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SKSohail Karimi
Sohail Karimi
APAkash G Patel
Akash G Patel
BNBharti P Nehete
Bharti P Nehete
PNPramod N Nehete
Pramod N Nehete
LDLudovic Debure
Ludovic Debure
HSHenrieta Scholtzova
Henrieta Scholtzova
Background: Advancements of novel therapeutic interventions for Alzheimer’s disease (AD) have been hindered by a lack of animal models in preclinical research that naturally recapitulate the pathologic features of disease with age. Our prior work demonstrated the utility of squirrel monkeys (SQMs), a non‐human primate (NHP) model of sporadic AD pathology with abundant cerebral amyloid angiopathy (CAA), as an opportune species to assess the potential therapeutic outcomes and safety profile of our novel immunomodulatory approach using TLR9 agonist CpG‐ODN. Here we provide the first longitudinal and cross‐sectional study on aging and disease pathogenesis in SQMs by characterizing blood/CSF biomarker signatures of AD/CAA pathology.Method: SIMOA, ELISA, and Luminex platform immunoassays were utilized to investigate age‐associated profiles of plasma and CSF biomarkers involved in neurodegeneration (NfL, GFAP), brain and peripheral inflammation/glia activation (YKL‐40/CHI3L1, sTREM2), and cerebrovascular dysfunction/BBB integrity (albumin index, bFGF, VCAM‐1, MMPs).Result: Cross‐sectional analysis revealed statistically significant differences in plasma NfL and GFAP levels between age groups ranging from 6 to 23 years old (NfL: one‐way ANOVA, f(6,84)) = 6.395, p<0.0001; GFAP: one‐way ANOVA, f(6,84)) = 8.111, p<0.0001). Preliminary assessments revealed significantly higher plasma YKL‐40/CHI3L1 and MMP1 levels, while VCAM‐1, bFGF, and MMP2 levels were significantly lower in the geriatric SQMs when compared to the young group. CSF analyses demonstrated significantly higher YKL‐40/CHI3L1 and bFGF levels, and an elevated albumin index among the geriatric cohort when compared to young monkeys. Moreover, a longitudinal follow‐up of a separate SQM cohort over three years (19‐22 years old) revealed a significant increase in plasma sTREM2 levels; neurogranin levels appeared to increase, but differences were not significant (p = 0.0625, Wilcoxon signed‐rank test). Further characterizations of fluid biomarker trajectories and their relationships with age‐associated changes in cognition and neuroimaging markers are forthcoming.Conclusion: SQMs present a valuable opportunity to evaluate biomarker signatures associated with aging and the development of cerebrovascular amyloid pathology. The use of this advantageous model is important to enhance the translational potential of novel therapeutics for human benefit.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
APAkash G Patel
Akash G Patel
SKSohail Karimi
Sohail Karimi
PNPramod N Nehete
Pramod N Nehete
BNBharti P Nehete
Bharti P Nehete
SMSean Murray
Sean Murray
HSHenrieta Scholtzova
Henrieta Scholtzova
Background: Innate immunomodulation has shown potential to be an effective therapeutic approach in ameliorating pathological features of Alzheimer’s Disease (AD). Our recently published study showed a reduction in cognitive deficits and AD‐related pathology in a squirrel monkey model (SQM) of sporadic cerebral amyloid angiopathy (CAA) following treatment with TLR9 agonist, Class B CpG ODN. Subsequently, we commenced a chronic treatment study evaluating the efficacy and safety of Class C CpG ODN in geriatric SQMs. Here, we further explore the efficacy of Class C CpG ODN by evaluating fluid biomarkers and implementing automated cognitive tests. Moreover, we assess the immunostimulatory profiles induced by Class B and Class C CpG ODNs using RNA‐Seq genome‐wide transcriptome analysis of SQM PBMCs.Method: Geriatric SQMs received monthly injections of CpG ODN‐C or saline (VEH) over three years. Fluid biomarkers for cerebrovascular dysfunction, neurodegeneration, and neuroinflammation were assessed by Luminex and SIMOA. Touchscreen‐based Automated Cognitive Testing System (ACTS) was applied among socially living SQMs to assess behavioral changes. RNA‐Seq analyses were performed using PBMCs isolated 24hrs following CpG ODN‐B and ‐C administrations in a separate cohort of elderly SQMs.Result: Our initial experiments confirmed the utility of SQMs for investigating plasma age‐associated neurodegeneration biomarkers, including NfL, GFAP, and neurogranin. Preliminary evaluation of cerebrovascular dysfunction‐related plasma biomarkers, such as MMPs, albumin index, bFGF, and VCAM, revealed no differences between our treatment groups at earlier time points. Although not significant, higher levels of plasma sTREM2 and YKL‐40 were observed in VEH monkeys compared to CpG ODN‐treated group. Concluding assessments will be performed in plasma collected at the end of the treatment period. Characterization of additional plasma/CSF biomarkers related to AD/neurodegeneration is underway. ACTS‐based two‐choice discrimination learning task revealed that CpG ODN‐treated group performed with a greater correct response rate than the VEH group. As expected, RNA‐Seq analyses of SQM PBMCs revealed significantly altered pathways, including Th1/Th2, TLR signaling, phagocytosis, chemokine signaling, interferon signaling, and senescence pathways, in addition to pathways involved in infiltration, activation, and recruitment of various immune cells.Conclusion: The study highlights the potential of the SQM model for future translational research on CAA/AD and for advancing innovative therapeutic interventions.

13 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YWYoussef Z Wadghiri
Youssef Z Wadghiri
SKSuleiman Khan
Suleiman Khan
MSMuhammad T. Soliman
Muhammad T. Soliman
JSJakub Szabo
Jakub Szabo
AMAudrey Murray
Audrey Murray
HSHenrieta Scholtzova
Henrieta Scholtzova
Cerebral amyloid angiopathy (CAA) is a prevalent cerebrovascular pathology in AD and contributes to amyloid-related imaging abnormalities (ARIA), a major complication of current anti-amyloid immunotherapy. Despite its growing clinical importance, critical gaps remain in the development of reliable biomarkers for antemortem diagnosis of CAA. Squirrel monkeys (SQMs) are a valuable non-human primate model with translational relevance due to their universal propensity to develop abundant CAA and spontaneous ARIA in geriatric animals. The present study employed R 2 *, the apparent transverse relaxation rate, which is sensitive to susceptibility-related tissue properties, including iron content and blood oxygenation levels, to monitor age-related brain pathology in SQMs with varying CAA severity. Young, early geriatric, and late geriatric SQMs underwent 7T MRI using a dual-purpose T 2 *-w 3D multi-gradient-echo sequence for high-resolution anatomy and quantitative R 2 * mapping, alongside T 2 -w/FLAIR imaging. Whole-brain and gray matter R 2 * increased with age. In contrast, white matter R 2 * showed an initial increase followed by a late-life reversal, likely reflecting age-related changes in myelin integrity, tissue microstructure, and tissue water content. MRI-histopathology correlation linked T 2 *-w MRI hypointensities to CAA-positive iron-laden vessels associated with perivascular inflammation and, in some cases, hemosiderin deposits. Here we confirmed the occurrence of ARIA-H and ARIA-E events in geriatric animals. SQMs provided a valuable opportunity to examine the underlying pathology of spontaneous ARIA-E, revealing distinctive tissue signatures associated with its manifestation. ARIA-E hyperintensities were characterized by reactive gliosis and BBB disruption, whereas more advanced lesions exhibited perivascular lymphocytic infiltration and evidence of myelin and axonal injury. The current study presents compelling evidence linking R 2 * alterations with CAA severity and ARIA-related tissue injury, providing a foundation for further advancing early detection of CAA, ARIA risk assessment, and treatment strategies.